Cargando…

Combining Targeted Radionuclide Therapy and Immune Checkpoint Inhibition for Cancer Treatment

The development of immunotherapy, in particular immune checkpoint inhibitors (ICI), has revolutionized cancer treatment in the past decades. However, its efficacy is still limited to subgroups of patients with cancer. Therefore, effective treatment combination strategies are needed. Here, radiothera...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kleinendorst, Simone C., Oosterwijk, Egbert, Bussink, Johan, Westdorp, Harm, Konijnenberg, Mark W., Heskamp, Sandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Association for Cancer Research 2022
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9433955/ https://www.ncbi.nlm.nih.gov/pubmed/35471557 http://dx.doi.org/10.1158/1078-0432.CCR-21-4332

Ejemplares similares

Tracers for non-invasive radionuclide imaging of immune checkpoint expression in cancer
por: Wierstra, Peter, et al.
Publicado: (2019)

Carbonic Anhydrase IX-Targeted α-Radionuclide Therapy with 225Ac Inhibits Tumor Growth in a Renal Cell Carcinoma Model
por: Merkx, Robin I. J., et al.
Publicado: (2022)

Fibroblast activation protein-targeted radionuclide therapy: background, opportunities, and challenges of first (pre)clinical studies
por: Privé, Bastiaan M., et al.
Publicado: (2023)

Case Report: A severe case of immunosuppressant-refractory immune checkpoint inhibitor-mediated colitis rescued by tofacitinib
por: Sweep, Mark W. D., et al.
Publicado: (2023)

Combination Therapy, a Promising Approach to Enhance the Efficacy of Radionuclide and Targeted Radionuclide Therapy of Prostate and Breast Cancer
por: Damiana, Tyrillshall S. T., et al.
Publicado: (2021)

Immune Checkpoints, Inhibitors and Radionuclides in Prostate Cancer: Promising Combinatorial Therapy Approach
por: Kgatle, Mankgopo M., et al.
Publicado: (2021)

Combination Strategies to Improve Targeted Radionuclide Therapy
por: Chan, Tiffany G., et al.
Publicado: (2020)

PSMA Ligands for Radionuclide Imaging and Therapy of Prostate Cancer: Clinical Status
por: Lütje, Susanne, et al.
Publicado: (2015)

Radionuclides for Targeted Therapy: Physical Properties
por: Stokke, Caroline, et al.
Publicado: (2022)

Integrin α(v)β(3)-targeted radionuclide therapy combined with immune checkpoint blockade immunotherapy synergistically enhances anti-tumor efficacy
por: Chen, Haojun, et al.
Publicado: (2019)

Mechanisms of Immune Checkpoint Inhibitor-Mediated Colitis
por: Westdorp, Harm, et al.
Publicado: (2021)

Targeted Radionuclide Therapy
por: Ersahin, Devrim, et al.
Publicado: (2011)

Letter to the editor: Hypoxia kinetics and histology in combined radiotherapy and oxidative phosphorylation inhibition effects on antitumor immunity
por: Boreel, Daan F, et al.
Publicado: (2021)

PD-L1 Antibody Pharmacokinetics and Tumor Targeting in Mouse Models for Infectious Diseases
por: Sandker, Gerwin G. W., et al.
Publicado: (2022)

Developments in Combining Targeted Radionuclide Therapies and Immunotherapies for Cancer Treatment
por: Kerr, Caroline P., et al.
Publicado: (2022)

In Vitro comparison of (213)Bi- and (177)Lu-radiation for peptide receptor radionuclide therapy
por: Chan, Ho Sze, et al.
Publicado: (2017)

Quantitative Imaging of Hypoxic CAIX-Positive Tumor Areas with Low Immune Cell Infiltration in Syngeneic Mouse Tumor Models
por: Boreel, Daan F., et al.
Publicado: (2023)

Imaging carbonic anhydrase IX as a method for monitoring hypoxia-related radioresistance in preclinical head and neck cancer models
por: Huizing, Fokko J., et al.
Publicado: (2021)

Modeling Early Radiation DNA Damage Occurring During (177)Lu-DOTATATE Radionuclide Therapy
por: Tamborino, Giulia, et al.
Publicado: (2022)

Combined PARP Inhibition and Immune Checkpoint Therapy in Solid Tumors
por: Peyraud, Florent, et al.
Publicado: (2020)

Synergism of Checkpoint Inhibitors and Peptide Receptor Radionuclide Therapy in the Treatment of Pituitary Carcinoma
por: Lin, Andrew L, et al.
Publicado: (2021)

Imaging the Rewired Metabolism in Lung Cancer in Relation to Immune Therapy
por: van Genugten, Evelien A. J., et al.
Publicado: (2022)

Targeted Radionuclide Therapy of Human Tumors
por: Gudkov, Sergey V., et al.
Publicado: (2015)

Introduction to Radiobiology of Targeted Radionuclide Therapy
por: Pouget, Jean-Pierre, et al.
Publicado: (2015)

Targeting Melanin in Melanoma with Radionuclide Therapy
por: Allen, Kevin J. H., et al.
Publicado: (2022)

Targeted Radionuclide Therapy of Cancer and Infections
por: van der Wal, Bart C. H., et al.
Publicado: (2023)

Peptide receptor radionuclide therapy using radiolabeled somatostatin analogs: focus on future developments
por: Bison, Sander M., et al.
Publicado: (2014)

Experimental rat bladder urothelial cell carcinoma models
por: Arentsen, Harm C., et al.
Publicado: (2009)

Quantitative Imaging of the Hypoxia-Related Marker CAIX in Head and Neck Squamous Cell Carcinoma Xenograft Models
por: Huizing, Fokko J., et al.
Publicado: (2018)

Dosimetric evaluation of radionuclides for VCAM-1-targeted radionuclide therapy of early brain metastases
por: Falzone, Nadia, et al.
Publicado: (2018)

CAIX-targeting radiotracers for hypoxia imaging in head and neck cancer models
por: Huizing, Fokko J., et al.
Publicado: (2019)

Novel radionuclide therapy combinations in prostate cancer
por: Inderjeeth, Andrisha–Jade, et al.
Publicado: (2023)

Dosimetric Analysis of the Short-Ranged Particle Emitter (161)Tb for Radionuclide Therapy of Metastatic Prostate Cancer
por: Bernhardt, Peter, et al.
Publicado: (2021)

The chemical tool-kit for molecular imaging with radionuclides in the age of targeted and immune therapy
por: Witney, Timothy H., et al.
Publicado: (2021)

Inter and intra-tumor somatostatin receptor 2 heterogeneity influences peptide receptor radionuclide therapy response
por: Feijtel, Danny, et al.
Publicado: (2021)

Case Report: Imaging immune checkpoint inhibitor-induced yin-yang effects in the brain
por: Bol, K. F., et al.
Publicado: (2023)

Prospects for combining immune checkpoint blockade with PARP inhibition
por: Li, Anping, et al.
Publicado: (2019)

From fixed activities to personalized treatments in radionuclide therapy: lost in translation?
por: Flux, G. D., et al.
Publicado: (2017)

Targeted Radionuclide Therapy Using Auger Electron Emitters: The Quest for the Right Vector and the Right Radionuclide
por: Idrissou, Malick Bio, et al.
Publicado: (2021)

Prospects in Folate Receptor-Targeted Radionuclide Therapy
por: Müller, Cristina, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ivqnuj53tkvqv0npf3lhe2pspp